Effects of ingesting eye drops When it comes to eye drops, they are intended for topical use, meaning they are designed to be applied to the eyes to treat various eye conditions. However, ingesting eye drops, whether accidentally or intentionally, can have harmful effects on the body. The effects of ingesting eye drops can vary […]
Background on Dry Eye Drops Dry eye drops, also known as artificial tears, are a common over-the-counter remedy for dry eye syndrome. This condition occurs when the eyes do not produce enough tears or the tears evaporate too quickly, leading to discomfort, redness, and blurred vision. Dry eye drops are designed to lubricate the eyes, […]
Overview of Recent Eye Drop Recall Incidents in the US Eye drop recalls have garnered significant attention in the United States due to safety concerns surrounding various products. These incidents have raised alarm among consumers and healthcare professionals alike, highlighting the importance of ensuring the safety and efficacy of eye care products. Recall Incidents Several […]
Duration of Treatment Understanding the recommended duration of using eye drops for pink eye is crucial for effective management of the condition. The duration of treatment may vary depending on the severity of the infection and the type of eye drops prescribed by your healthcare provider. Types of Eye Drops There are different types of […]
Where to Find Rohto Eye Drops at Local Pharmacies When looking for Rohoto eye drops, local pharmacies can be a convenient option. The following drugstore chains typically carry a selection of Rohto eye drops: CVS Walgreens Rite Aid These pharmacies offer a variety of Rohto eye drops that cater to different needs, whether you are […]
Effects of using too many eye drops Using too many eye drops can have negative effects on your eyes and overall health. While eye drops are generally safe when used as directed, overusing them can lead to various issues. Some of the potential consequences of using too many eye drops include: Eye irritation Allergic reactions […]
— INO-8875 represents new mechanism of action to treat glaucoma by targeting the trabecular meshwork — LEXINGTON Mass., — June 25, 2009 — Inotek Pharmaceuticals today announced positive top-line results from a Phase 1/2 randomized, double-blind, placebo-controlled clinical trial of the Company’s lead candidate, INO-8875, in patients with glaucoma. Treatment with INO-8875 was well tolerated […]
— Phase 2 study to evaluate trabodenoson in combination with latanoprost expected to begin in 2013 — LEXINGTON, MA — September 27th, 2013 — Inotek Pharmaceuticals Corp., a leader in the development of innovative products for the treatment of glaucoma, today announced that it has closed on a $21 million financing. Proceeds from this financing […]
LEXINGTON Mass.,– April 28, 2009 Inotek Pharmaceuticals today announced that preclinical data supporting the Company’s lead clinical-stage drug candidate in glaucoma, INO-8875, will be presented in a poster session at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) 2009 Annual Meeting in Fort Lauderdale, FL. INO-8875 is a highly selective adenosine-1 receptor agonist […]
INO-8875 currently in Phase 1/2 clinical trial, results anticipated mid-2009 LEXINGTON Mass.,– May 6, 2009 Inotek Pharmaceuticals today presented positive preclinical results supporting the Company’s lead clinical-stage drug candidate in glaucoma, INO-8875. INO-8875 is a highly selective adenosine-1 (A1) receptor agonist in development as a topical agent for the treatment of elevated intraocular pressure (IOP) […]
